Malaria Vaccine: Do We Have a Magic Bullet?
Glaxo Smith Kline has been conducting Phase 3 trials on a malaria vaccine in Africa, which has been reported recently in New England Journal of Medicine. Dr. Satyajit Rath discusses with Newsclick the importance of such a vaccine and whether the results indicate that it would indeed be useful in the fight against malaria.
Get the latest reports & analysis with people's perspective on Protests, movements & deep analytical videos, discussions of the current affairs in your Telegram app. Subscribe to NewsClick's Telegram channel & get Real-Time updates on stories, as they get published on our website.
